Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Other Non-Current Assets (2016 - 2025)

Traws Pharma's Other Non-Current Assets history spans 14 years, with the latest figure at $104000.0 for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $104000.0 for Q4 2025, up 10300.0% from a year ago — trailing twelve months through Dec 2025 was $104000.0 (up 10300.0% YoY), and the annual figure for FY2025 was $104000.0, up 10300.0%.
  • Other Non-Current Assets for Q4 2025 was $104000.0 at Traws Pharma, down from $240000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $244000.0 in Q2 2025 to a low of $1000.0 in Q3 2022.
  • The 5-year median for Other Non-Current Assets is $5500.0 (2021), against an average of $56400.0.
  • The sharpest move saw Other Non-Current Assets tumbled 93.33% in 2021, then soared 24300.0% in 2025.
  • Year by year, Other Non-Current Assets stood at $10000.0 in 2021, then crashed by 90.0% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then changed by 0.0% to $1000.0 in 2024, then soared by 10300.0% to $104000.0 in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $104000.0, $240000.0, and $244000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.